Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;15(3):303-9.
doi: 10.1007/s10238-014-0296-3. Epub 2014 Jun 13.

Influencial factors of the performance of interferon-γ release assays in the diagnosis of childhood tuberculosis

Affiliations

Influencial factors of the performance of interferon-γ release assays in the diagnosis of childhood tuberculosis

Tao Li et al. Clin Exp Med. 2015 Aug.

Abstract

Diagnosis of active tuberculosis (TB) in children remains difficult. This study aimed at evaluating the ability of interferon-gamma release assays (IGRAs) in the detection of active TB in human immunodeficiency virus-negative children vaccinated with Bacille Calmette-Guérin and investigating the effect of prednisolone treatment on the IGRAs performance. Among the 162 children with suspected TB disease recruited in China, 60 were tested with QuantiFERON-TB Gold In Tube (QFT-GIT) and 102 were tested with T-SPOT.TB. QFT-GIT presented a sensitivity of 83.9 % (95 % CI 66.9-93.4 %) and a specificity of 88.5 % (95 % CI 70.2-96.8 %), while T-SPOT.TB had a sensitivity of 75.9 % (95 % CI 63.4-85.2 %) and a specificity of 94.7 % (95 % CI 81.8-99.5 %). The positive predictive value was high in both assays, 92.9 % for QFT-GIT and 95.7 % for T-SPOT.TB. In total of these two kinds of IGRAs, false negative rate was significantly higher in children receiving systemic prednisolone (1 mg/kg/day) therapy for >1 week (two tested with T-SPOT.TB and five tested with QFT-GIT) than in those with ≤1 week of prednisolone therapy and without prednisolone therapy (57.1 vs. 18.3 %, p = 0.035). There was no significant difference of the positive rate of both tests in children <5 years old compared with those ≥5 years old. Both types of IGRAs showed good diagnostic values in detecting childhood TB before microbiological evidence was available. Glucocorticoids had a significant negative influence on IGRAs if treated for >1 week. Age made no difference on the performance of these tests in children.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Recruitment and diagnostic classification of all participants
Fig. 2
Fig. 2
Effects of prednisolone treatment on T-SPOT.TB and QFT-GIT results of children with ATB (w week)

References

    1. Organization WH. Global tuberculosis control: WHO report 2012. Genava: WHO; 2012.
    1. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax. 2002;57(9):804–809. doi: 10.1136/thorax.57.9.804. - DOI - PMC - PubMed
    1. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest. 2007;131(6):1898–1906. doi: 10.1378/chest.06-2471. - DOI - PubMed
    1. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest. 2010;137(4):952–968. doi: 10.1378/chest.09-2350. - DOI - PubMed
    1. Feng Y, Diao N, Shao L, Wu J, Zhang S, Jin J, Wang F, Weng X, Zhang Y, Zhang W. Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis. PLoS ONE. 2012;7(3):e32652. doi: 10.1371/journal.pone.0032652. - DOI - PMC - PubMed

Publication types

LinkOut - more resources